Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation

scientific article published in October 2005

Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00075484-200510000-00005
P698PubMed publication ID16215448

P2093author name stringRicardo Muñoz
Alan Bostrom
Victor I Reus
Gary L Humfleet
James M Lightwood
Sharon M Hall
P2860cites workA randomized trial of nortriptyline for smoking cessationQ34475866
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineQ41155678
Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesQ41231603
Psychological intervention and antidepressant treatment in smoking cessationQ43568906
Extended nortriptyline and psychological treatment for cigarette smokingQ45130111
Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.Q45938730
Statistical inference for cost-effectiveness ratios.Q52265200
The usefulness of average cost-effective ratiosQ61876748
Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research ProgramQ68176260
A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium RepresentativesQ73924114
P433issue4
P304page(s)381-392
P577publication date2005-10-01
P1433published inJournal of Behavioral Health Services and ResearchQ15757216
P1476titleCost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation.
P478volume32

Reverse relations

cites work (P2860)
Q34288059A multi‐level analysis of non‐significant counseling effects in a randomized smoking cessation trial
Q24201167Antidepressants for smoking cessation
Q84449266Assessing preferences for improved smoking cessation medications: a discrete choice experiment
Q35751878Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence
Q35217687Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists
Q35451969Cost-effectiveness of computed tomography screening for lung cancer in the United States
Q28757732Effects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smoking
Q47140311Evaluation of smoking cessation intervention in patients with chronic diseases in smoking cessation clinics
Q36150616From online randomized controlled trials to participant preference studies: morphing the San Francisco Stop Smoking site into a worldwide smoking cessation resource
Q56212484Group behaviour therapy programmes for smoking cessation
Q28277165New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?
Q37138047Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials
Q34602493Relationship between momentary affect states and self-efficacy in adolescent smokers
Q33452790Smiling Instead of Smoking: Development of a Positive Psychology Smoking Cessation Smartphone App for Non-daily Smokers
Q34779470The use of bupropion SR in cigarette smoking cessation
Q47765206Why are antidepressant drugs effective smoking cessation aids?